We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




MIS Cryotherapy for Kidney Tumors

By HospiMedica staff writers
Posted on 05 Aug 2002
Doctors at the University of Virginia Medical Center (UVA, Richmond, USA) treated a renal cell carcinoma in the left kidney of a 64-year-old man by using cryotherapy, eliminating the need for surgery and its complications.

The minimally invasive procedure took less than 55 minutes. More...
Doctors froze the tumor with ultra-thin needles inserted directly through the skin, using cryotherapy technology. UVA radiologists used real-time ultrasound to guide the needles to their target, where a template aligned and held them in place through two freeze/thaw cycles, which completely ablated the tumor. In this procedure, doctors used the SeedNet Gold system and CryoNeedles from Galil Medical, Ltd. (Yokneam, Israel).

When a computed tomography scan showed the 2.5 cm mass on the man's left side two months ago, a partial nephrectomy seemed to be the only option. Doctors had removed the patient's left kidney over a year ago. Now, the risk of losing the remaining kidney led to the decision to use cryosurgery. Patients undergoing this procedure can leave the hospital the same day and expect recuperation in a few days, versus laparoscopic removal (one to two days in hospital and about two weeks at home) or open surgery (one week in hospital and six weeks at home), says Galil.

"Those small CryoNeedles make this type of surgery possible,” said Dr. Theodorescu, professor of urology in UVA's department of urology. "Large conventional probes would be difficult to insert percutaneously and to direct into the kidney as well as control during the freezing process.” Dr. Theodorescu also noted that patient selection is the key to success. Patients should have tumors less than 3 cm and these should be in an anatomical position that can be viewed clearly by ultrasound.


UVA >>



Related Links:
Galil
University of Virginia Medical Center

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.